Ricin
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: > Other > Ricin
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.49.00.10
Ricin Toxin for Vaccine Research
Purified ricin toxin derived from Ricinus communis seeds, used in immunological research for developing antitoxin vaccines. Classified under HTS 3002.49.0010 as a toxin for therapeutic or prophylactic applications in biotechnology processes. It is handled under strict biosafety protocols due to its potency.
Ricin Toxoid for Prophylactic Vaccine Trials
Detoxified ricin toxoid used in phase I/II vaccine trials for inducing immunity against ricin exposure. Fits HTS 3002.49.0010 as a toxin for prophylactic uses in clinical settings. Developed for military and civilian biodefense.
Research-Grade Ricin for Toxin Neutralization Assays
Standardized ricin for in vitro neutralization assays testing antitoxin efficacy. Under HTS 3002.49.0010 as a diagnostic immunological product. Critical for validating therapeutic antibodies.
Castor-Derived Ricin for Biodefense Countermeasures
Ricin extracted from castor beans for biodefense programs developing countermeasures. Classified HTS 3002.49.0010 as a toxin for prophylactic research. Used by government labs.
Lyophilized Ricin for Diagnostic Controls
Freeze-dried ricin used as positive control in ricin exposure diagnostic tests. HTS 3002.49.0010 for diagnostic immunological products. Stable form for lab reagents.
Ricin B-Chain for Targeted Therapy Research
Purified ricin B-chain for engineering targeted delivery in immunotoxins. Under HTS 3002.49.0010 as biotech-modified toxin. For cancer and infectious disease therapies.
Ricin Antitoxin Development Toxin
Highly purified ricin for use in producing monoclonal antibodies and antitoxins against ricin poisoning. Falls under HTS 3002.49.0010 as an immunological product obtained via biotechnological processes for prophylactic purposes. Essential for biodefense research programs.
Biotechnological Ricin for Immunological Studies
Recombinant ricin toxin produced through biotech processes for studying immune responses and antibody production. Classified in HTS 3002.49.0010 as a modified toxin for diagnostic and therapeutic research. Used in labs to develop countermeasures against bioterrorism agents.
Purified Ricin A-Chain for Antibody Conjugates
Isolated ricin A-chain protein for conjugating with monoclonal antibodies in cancer immunotherapy research. HTS 3002.49.0010 covers this as an immunological product from biotech processes. Key component in targeted toxin therapies.
Ricin for Monoclonal Antibody Production
Ricin antigen for immunizing animals to produce anti-ricin monoclonal antibodies. HTS 3002.49.0010 for such biotechnological immunological products. Foundation for diagnostic and therapeutic MABs.